A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic Pontine Glioma Linked to TP53 Alterations By Ogkologos - May 12, 2026 187 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BIOMEDE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR The Future Front Line: Pre-Med During COVID-19 September 8, 2020 Final DFS Analysis Demonstrates that Adjuvant Osimertinib Improves DFS in Patients... February 13, 2023 Por qué el registro de médula ósea necesita más donantes diversos... February 8, 2022 How the Cancer Community Can Help Close the Care Gap This... February 4, 2022 Load more HOT NEWS R2-ISS: an Improved and Simple Prognostic Staging System Allows Better Stratification... Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities FDA Grants Traditional Approval to Encorafenib for mCRC with a BRAF... Oligoprogression in Metastatic NSCLC Could Be Effectively Treated with SBRT Plus...
